The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension
Launched by GULHANE SCHOOL OF MEDICINE · Jun 15, 2009
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
The patients who were non-obese (BMI\<30kg/m2), non dyslipidemic (total cholesterol \<200mg/dl, Triglyceride\<150mg/dl), and free of cardiovascular events (negative medical history, negative ECG findings) were investigated for enrollment. CKD stage 1 patients older than 18 years of age and willing to participate to the study were screened. From the 375 patients with established type 2 diabetes mellitus+hypertension, 174 had proteinuria and/or hypertension (24 h protein excretion 1-2 g/day, systolic blood pressures ≥140mmHg and/or diastolic blood pressures ≥ 90 mmHg, respectively). All cases...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • CKD stage 1 patients
- • Older than 18 years of age
- • Type 2 Diabetic patients
- • Proteinuria
- • Hypertension
- Exclusion Criteria:
- • History of coronary artery disease
- • Smokers
- • Taking statins or renin-angiotensin blockers
About Gulhane School Of Medicine
Gulhane School of Medicine is a prestigious medical institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence in education and patient care, the school fosters a collaborative environment where multidisciplinary teams work to explore new treatment modalities and enhance medical knowledge. By engaging in rigorous clinical research, Gulhane School of Medicine aims to contribute to the development of effective therapies and improve health outcomes, ultimately benefitting both the local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Mahmut Ilker Yilmaz, MD
Principal Investigator
GATA
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials